We are live on ! Find out more
FLNA

Filana Therapeutics

87 hedge funds and large institutions have $154M invested in Filana Therapeutics in 2014 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 30 increasing their positions, 21 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

5,000% more call options, than puts

Call options by funds: $612K | Put options by funds: $12K

100% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 12

43% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 21

16% more funds holding

Funds holding: 7587 (+12)

13% more capital invested

Capital invested by funds: $137M → $154M (+$17.2M)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

Holders
87
Holders Change
+12
Holders Change %
+16%
% of All Funds
2.5%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.11%
New
24
Increased
30
Reduced
21
Closed
12
Calls
$612K
Puts
$12K
Net Calls
+$600K
Net Calls Change
-$341K
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
26
Fidelity Investments
Massachusetts
$838K
TCIM
27
TIAA CREF Investment Management
New York
$777K +$714K +19,302 New
Northern Trust
28
Northern Trust
Illinois
$727K +$193K +5,215 +41%
Susquehanna International Group
29
Susquehanna International Group
Pennsylvania
$723K -$53.1K -1,435 -7%
Bank of America
30
Bank of America
North Carolina
$708K -$92K -2,485 -12%
SIM
31
Spark Investment Management
New York
$653K +$309K +8,357 +106%
TA
32
Teton Advisors
New York
$638K
ACM
33
Avalon Capital Management
California
$637K
Jane Street
34
Jane Street
New York
$615K +$325K +8,770 +134%
BIM
35
BlackRock Investment Management
Delaware
$609K +$560K +15,123 New
MERSOM
36
Municipal Employees' Retirement System of Michigan
Michigan
$590K
Two Sigma Investments
37
Two Sigma Investments
New York
$582K +$244K +6,587 +84%
California Public Employees Retirement System
38
California Public Employees Retirement System
California
$575K
PCM
39
Palisade Capital Management
New Jersey
$575K +$106K +2,857 +25%
Morgan Stanley
40
Morgan Stanley
New York
$525K -$631K -17,040 -57%
Millennium Management
41
Millennium Management
New York
$510K +$469K +12,664 New
CS
42
Credit Suisse
Switzerland
$500K +$41.9K +1,131 +10%
GCP
43
GSA Capital Partners
United Kingdom
$480K +$441K +11,913 New
Charles Schwab
44
Charles Schwab
California
$428K +$295K +7,972 +300%
PAM
45
Panagora Asset Management
Massachusetts
$427K -$9.03K -244 -2%
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$400K +$367K +9,929 New
GS
47
Gagnon Securities
New York
$355K -$45.2K -1,221 -12%
TA
48
Teachers Advisors
New York
$303K +$279K +7,533 New
Invesco
49
Invesco
Georgia
$301K +$11.5K +312 +4%
AQR Capital Management
50
AQR Capital Management
Connecticut
$282K +$42.3K +1,143 +19%

FLNA Hedge Fund Activity: Q2 2014 in Review

87 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q2 2014, worth a combined $154M — up 13% from $137M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new FLNA positions and 12 closed out — a net gain of 12 holders — while 30 added to existing stakes and 21 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $4.44M. The largest seller was Broadfin Capital, exiting entirely with an estimated $4.29M sold.

  • 87 institutional investors held Filana Therapeutics (FLNA) as of Q2 2014, up from 75 in Q1 2014.
  • Funds reported $154M of Filana Therapeutics stock for Q2 2014, up 13% quarter-over-quarter.
  • 24 funds opened new Filana Therapeutics positions in Q2 2014 and 12 closed out, a net change of +12 holders.
  • The largest Filana Therapeutics buyer in Q2 2014 was BlackRock Fund Advisors, an estimated $4.44M added.
  • The largest Filana Therapeutics seller in Q2 2014 was Broadfin Capital, an estimated $4.29M sold.

Based on aggregated 13F filings for Q2 2014.